Moderna does one better than Pfizer/BioNTech; touts 94.5% efficacy for its Covid vaccine
The company is the second this month to report promising results for a Covid-19 vaccine even as the virus rages across the U.S.
‘Breakthrough finding’ reveals why certain Covid patients die
Interferons serve as the body’s first line of defense against infection, sounding the alarm and activating an army of virus-fighting genes. Lab studies show interferons are suppressed in some people with Covid-19, perhaps by the virus itself.
What Are Healthcare Organizations Getting Wrong about Email Security?
A new report by Paubox calls for healthcare IT leaders to dispose of outdated assumptions about email security and address the challenges of evolving cybersecurity threats.
Beyond the pandemic: Harnessing the power of real time insights
When all key health stakeholders are connected at the hub, common insights can be leveraged, allowing all healthcare providers to respond intelligently, without delay and ultimately make the best decisions possible for their patients.
Covid-19 patient groups fight back against viral false information
Fear and uncertainty regarding the coronavirus have made online groups targets for the spread of false information and to help fellow patients, some of these groups are making it a mission to stamp out misinformation.
Important questions about Pfizer’s Covid-19 vaccine
News of positive results from Pfizer's Covid-19 vaccine is heartening but historically, important scientific announcements about vaccines are made through peer-reviewed medical research papers that have undergone extensive scrutiny about study design, results and assumptions, not through company press releases.
With 90% efficacy against Covid-19, Pfizer/BioNTech’s vaccine jumps ahead in global race
The news sent the stock market soaring as it represents a key milestone in developing and distributing a vaccine for the virus. Still public confidence in vaccines need to be boosted, an expert noted.
presented by
A Path to Healing: Discovering Arizona’s PTSD Treatment Centers
Explore top PTSD treatment centers in Arizona, offering personalized care, holistic therapies and expert support to help individuals heal and reclaim their lives.
Covid-19 didn’t just disrupt healthcare, it accelerated industry change
Many of the strategies that were on the bottom of the priority list in early 2020 may have moved up, with a new focus on digital enablement and other technological capabilities.
Medicare to cover all FDA-approved Covid-19 vaccines
CMS' interim rule states that Medicare will cover Covid-19 vaccines approved by the FDA, including those receiving emergency use authorization, in a reversal from its usual policy. The vaccine will be made available at no cost to Medicare beneficiaries.
The trough and the tidal wave: How health insurers can get ahead of the looming demand
Deferred care because of Covid-19 will lead to additional stress on the healthcare system in the very near future and here's how insurers can manage it.
Why prioritizing health equity in the Covid-19 vaccine distribution is not just right, but necessary
Even though Covid-19 is distinct from any health crisis the country has previously faced, assessing U.S. public health strategies during past crises can provide insight into what has contributed to a more or less equitable response.
The Human Algorithm: What AI Can’t Replace in Pharma Engagement
At a time when AI is reshaping pharma, Reverba Global CEO Cheryl Lubbert explained in an interview why empathy, context, and ethics still require a human touch.
Demand rises for single-use surgical technologies in the era of Covid-19
There is a surging demand for pre-sterilized surgical technologies at healthcare facilities because of the desire to both curb risk factors associated with Covid-19 at hospitals and also reduce the possibility of bacterial co-infections.
Technology can ease pandemic challenges faced by hospitals, ambulatory surgery centers
To keep critical revenue flowing, hospitals and ambulatory surgery centers need to resume elective surgeries and procedures as quickly as possible and mobile apps can help by giving patients and staff vital information, provide advance symptom screening and help providers reduce elective procedure no-shows through better patient compliance.
Landmark FDA approval of antiviral drug as 1st COVID-19 treatment comes amid conflicting efficacy data
The Food and Drug Administration approved Gilead's antiviral drug as the first treatment for Covid-19 but just last week a WHO report showed that the drug appeared to have little to no effect on hospitalized patients.
Covid-19 has presented the possibility of reinventing healthcare delivery and reimbursement must support this
While there are encouraging signs of reimbursement falling in step with the move towards a more value-based healthcare system, what is needed now to further encourage healthcare innovators is to properly rationalize approval processes imposed by the FDA and CMS.
Cue Health gets $481M to expand production of rapid coronavirus test
San Diego-based diagnostics startup Cue Health won a $481 million from the Department of Health and Human Services and the Department of Defense to produce more coronavirus tests. The company received an emergency use authorization in June for its rapid molecular test.